Cytokeratin 10 (PTR1360) mouse mAb

    • Catalog No.:YM4775
    • Applications:WB;ELISA
    • Reactivity:Human; Mouse; Rat;
      • Target:
      • Cytokeratin 10
      • Fields:
      • >>Estrogen signaling pathway;>>Staphylococcus aureus infection
      • Gene Name:
      • KRT10 KPP
      • Protein Name:
      • Cytokeratin-10
      • Human Gene Id:
      • 3858
      • Human Swiss Prot No:
      • P13645
      • Immunogen:
      • Synthesized peptide derived from human protein.AA range: 100-200
      • Specificity:
      • This antibody detects endogenous levels of Cytokeratin 10.
      • Formulation:
      • PBS, 50% glycerol, 0.05% Proclin 300, 0.05%BSA
      • Dilution:
      • WB 1:500-1000, ELISA: 1:5000-20000.
      • Purification:
      • Protein G
      • Storage Stability:
      • -15°C to -25°C/1 year(Do not lower than -25°C)
      • Other Name:
      • Keratin, type I cytoskeletal 10 (Cytokeratin-10;CK-10;Keratin-10;K10)
      • Molecular Weight(Da):
      • 60kD
      • Observed Band(KD):
      • 70kD
      • Background:
      • This gene encodes a member of the type I (acidic) cytokeratin family, which belongs to the superfamily of intermediate filament (IF) proteins. Keratins are heteropolymeric structural proteins which form the intermediate filament. These filaments, along with actin microfilaments and microtubules, compose the cytoskeleton of epithelial cells. Mutations in this gene are associated with epidermolytic hyperkeratosis. This gene is located within a cluster of keratin family members on chromosome 17q21. [provided by RefSeq, Jul 2008],
      • Function:
      • disease:Defects in KRT10 are a cause of bullous congenital ichthyosiform erythroderma (BCIE) [MIM:113800]; also known as epidermolytic hyperkeratosis (EHK) or bullous erythroderma ichthyosiformis congenita of Brocq. BCIE is an autosomal dominant skin disorder characterized by widespread blistering and an ichthyotic erythroderma at birth that persist into adulthood. Histologically there is a diffuse epidermolytic degeneration in the lower spinous layer of the epidermis. Within a few weeks from birth, erythroderma and blister formation diminish and hyperkeratoses develop.,disease:Defects in KRT10 are a cause of epidermal nevus epidermolytic hyperkeratotic type [MIM:600648]. Epidermal nevi affect about 1 in 1,000 people. They appear at or shortly after birth as localized lines of epidermal thickening. The extent of skin involvement varies widely.,disease:Defects in KRT10 are a cause of icht
      • Subcellular Location:
      • Cytoplasmic, Membranous
      • Expression:
      • Seen in all suprabasal cell layers including stratum corneum. Expressed on the surface of lung cell lines (PubMed:19627498).
      • Products Images
      • Whole cell lysates were separated by 10% SDS-PAGE, and the membrane was blotted with anti-Cytokeratin 10 (PTR1360) antibody. The HRP-conjugated Goat anti-Rabbit IgG(H + L) antibody was used to detect the antibody. Lane 1: mouse skin Predicted band size: 60kDa Observed band size: 70kDa The 55kd of non-specific band is probably endogenous antibody heavy chain of mouse skin tissue.